ABVC BioPharma, Inc. Equity Securities, FV-NI, Realized Gain (Loss)
ABVC BioPharma, Inc. (ABVC) reported Equity Securities, FV-NI, Realized Gain (Loss) of -$221.89 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-13.
Discontinued › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiRealizedGainLoss · last filed 2024-03-13
- ABVC BioPharma, Inc. equity securities, fv-ni, realized gain (loss) for the quarter ending 2021-12-31 was -$76.70K.
- ABVC BioPharma, Inc. equity securities, fv-ni, realized gain (loss) for the quarter ending 2021-09-30 was -$91.77K.
- ABVC BioPharma, Inc. equity securities, fv-ni, realized gain (loss) for the quarter ending 2021-06-30 was -$53.59K.
- ABVC BioPharma, Inc. equity securities, fv-ni, realized gain (loss) for the quarter ending 2021-03-31 was -$47.79K.
- ABVC BioPharma, Inc. equity securities, fv-ni, realized gain (loss) for fiscal 2023 was -$221.89K.
- ABVC BioPharma, Inc. equity securities, fv-ni, realized gain (loss) for fiscal 2021 was -$269.84K.
- ABVC BioPharma, Inc. equity securities, fv-ni, realized gain (loss) for fiscal 2020 was -$1.17M.
- ABVC BioPharma, Inc. equity securities, fv-ni, realized gain (loss) for fiscal 2019 was -$210.09K.
| Period end | Equity Securities, FV-NI, Realized Gain (Loss) 3 month | Equity Securities, FV-NI, Realized Gain (Loss) 6 month | Equity Securities, FV-NI, Realized Gain (Loss) 9 month | Equity Securities, FV-NI, Realized Gain (Loss) 12 month | Equity Securities, FV-NI, Realized Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | -$221.89K 10-K · filed 2024-03-13 | ||||
| 2021-12-31 | -$76.70K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$168.46K derived: sum of 2 quarters · filed 2023-03-31 | -$222.05K derived: sum of 3 quarters · filed 2023-03-31 | -$269.84K 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$91.77K 10-Q · filed 2022-11-14 | -$145.36K derived: sum of 2 quarters · filed 2022-11-14 | -$193.15K 10-Q · filed 2022-11-14 | -$294.58K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$53.59K 10-Q · filed 2022-08-15 | -$101.38K 10-Q · filed 2022-08-15 | -$202.82K derived: sum of 3 quarters · filed 2022-08-15 | -$1.09M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | -$47.79K 10-Q · filed 2022-05-16 | -$149.23K derived: sum of 2 quarters · filed 2022-05-16 | -$1.04M derived: sum of 3 quarters · filed 2022-05-16 | -$1.15M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | -$101.44K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$988.67K derived: sum of 2 quarters · filed 2022-03-31 | -$1.10M derived: sum of 3 quarters · filed 2022-03-31 | -$1.17M 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$887.23K 10-Q · filed 2021-11-15 | -$996.89K derived: sum of 2 quarters · filed 2021-11-15 | -$1.07M 10-Q · filed 2021-11-15 | -$1.10M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | -$109.66K 10-Q · filed 2021-08-12 | -$180.07K 10-Q · filed 2021-08-12 | -$208.04K derived: sum of 3 quarters · filed 2021-08-12 | -$272.73K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$70.41K 10-Q · filed 2021-05-10 | -$98.38K derived: sum of 2 quarters · filed 2021-05-10 | -$163.07K derived: sum of 3 quarters · filed 2021-05-10 | -$214.29K derived: sum of 4 quarters · filed 2021-05-10 | |
| 2019-12-31 | -$27.97K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$92.66K derived: sum of 2 quarters · filed 2021-03-16 | -$143.88K derived: sum of 3 quarters · filed 2021-03-16 | -$210.09K 10-K · filed 2021-03-16 | |
| 2019-09-30 | -$64.69K 10-Q · filed 2020-11-17 | -$115.91K derived: sum of 2 quarters · filed 2020-11-17 | -$182.11K 10-Q · filed 2020-11-17 | -$210.48K derived: sum of 4 quarters · filed 2020-11-17 | |
| 2019-06-30 | -$51.22K 10-Q · filed 2020-08-14 | -$117.42K 10-Q · filed 2020-08-14 | -$145.79K derived: sum of 3 quarters · filed 2020-08-14 | -$184.95K derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | -$66.20K 10-Q · filed 2020-06-29 | -$94.57K derived: sum of 2 quarters · filed 2020-06-29 | -$133.73K derived: sum of 3 quarters · filed 2020-06-29 | -$220.65K derived: sum of 4 quarters · filed 2020-06-29 | |
| 2018-12-31 | -$28.36K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-15 | -$67.53K derived: sum of 2 quarters · filed 2020-05-15 | -$154.44K derived: sum of 3 quarters · filed 2020-05-15 | -$193.01K 10-K · filed 2020-05-15 | -$2.55M 10-K · filed 2019-04-15 |
| 2018-09-30 | -$39.17K 10-Q · filed 2019-11-18 | -$126.08K derived: sum of 2 quarters · filed 2019-11-18 | -$164.65K 10-Q · filed 2019-11-18 | ||
| 2018-06-30 | -$86.92K 10-Q · filed 2019-08-09 | -$125.48K 10-Q · filed 2019-08-09 | |||
| 2018-03-31 | -$38.57K 10-Q · filed 2019-05-28 |